Axis Punch:Jubilant Ingrevia Ltd. - 24th September, 2026
Broad-Based Recovery Supports Earnings Trajectory: Jubilant Ingrevia Ltd. delivered a healthy start to FY27, with all three business segments...
97 Views
Chemicals and Midcaps - Q2FY27E: Result Preview
We expect Q2FY27 to witness a gradual YoY recovery across the chemicals sector, led by improved realizations, recovering fluorochemical exports and...
89 Views
Jubilant Ingrevia Ltd - A Structural Shift Towards Higher-Value Chemistry
Jubilant Ingrevia Limited completed a pivotal fiscal year, marked by the successful execution of its aggressive three-year, Rs 2,000+ Cr CapEx...
107 Views
Jubilant Ingrevia Ltd - Specialty & CDMO Momentum Accelerates
The commissioning of the Bharuch Agro CDMO facility and expanding pharma CDMO pipeline provide strong medium-term earnings visibility.
119 Views
Q1FY27 Consolidated Earnings Preview
The Q1FY27 earnings season unfolds against a backdrop of relatively better global conditions, making corporate earnings and management commentary...
106 Views